Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “cycloserine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 11
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 11 pipeline programs matching "cycloserine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

11 results for “cycloserine” Back to intelligence hub

Search results

  1. D-cycloserine

    United Therapeutics Europe Ltd

    Autistic Disorder

    phase 3 small molecule completed

    1 trial
  2. DCS (D-Cycloserine ) + Prolonged Imaginal Exposure

    United Therapeutics Europe Ltd

    Post Traumatic Stress Disorder

    phase 3 small molecule completed

    1 trial
  3. Cycloserine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 2 small molecule terminated

    1 trial
  4. D-Cycloserine

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 2 small molecule terminated

    1 trial
  5. D-Cycloserine (DCS)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorders

    phase 2 small molecule completed

    1 trial
  6. D-cycloserine

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 2 small molecule terminated

    1 trial
  7. d-cycloserine

    BRIGHT MINDS BIOSCIENCES INC.

    Panic Disorder

    phase 2 small molecule completed

    1 trial
  8. d-cycloserine

    BRIGHT MINDS BIOSCIENCES INC.

    COCAINE-RELATED DISORDERS

    phase 2 small molecule completed

    1 trial
  9. Cycloserine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Addiction

    phase 1 small molecule completed

    1 trial
  10. d-cycloserine

    United Therapeutics Europe Ltd

    Chronic Obstructive Pulmonary Disease

    phase 1 small molecule active

    1 trial
  11. Seromycin (D-cycloserine, DCS)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Addiction

    small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.